Literature DB >> 3202483

Pulmonary lysozyme--a secretory protein of type II pneumocytes in the rat.

G Singh1, S L Katyal, W E Brown, D L Collins, R J Mason.   

Abstract

A 14 kDa basic protein isolated from rat lung lavage was demonstrated to be lysozyme by its amino acid sequence analysis. An antiserum to rat lysozyme stained type II pneumocytes and alveolar macrophages. In rat lungs, no staining of the airway cells was noted. Lysozyme was detectable in type II pneumocytes by immunocytochemistry and by a quantitative immunoassay of lung homogenates of fetal lungs at Day 20 of gestation. An increase in the lysozyme content of the lung with increasing gestational and postnatal age of the rat was noted. In adult animals, lysozyme accounts for about 169.0 micrograms/g of wet lung weight and 0.3% of the soluble proteins in lung homogenate. Lysozyme constitutes about 6.6% of the total soluble proteins in rat lung lavage. Metabolic labeling and immunoprecipitation were used to demonstrate that rat type II pneumocytes synthesize and secrete lysozyme in vitro. However, in human lungs, lysozyme was identified in serous submucosal glands but not in alveolar type II pneumocytes. The results demonstrate differential distribution of a secretory protein in rodent and human lungs and indicate that in the rat lysozyme could be used as an immunohistologic marker for type II pneumocytes and as an indicator of secretory activity and maturation of type II pneumocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202483     DOI: 10.1164/ajrccm/138.5.1261

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth.

Authors:  Olga D Chuquimia; Dagbjort H Petursdottir; Natalia Periolo; Carmen Fernández
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

2.  Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection.

Authors:  Jesús Arcos; Smitha J Sasindran; Nagatoshi Fujiwara; Joanne Turner; Larry S Schlesinger; Jordi B Torrelles
Journal:  J Immunol       Date:  2011-05-20       Impact factor: 5.422

3.  GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer.

Authors:  Anna-Karin M Sjogren; Karin M E Andersson; Meng Liu; Briony A Cutts; Christin Karlsson; Annika M Wahlstrom; Martin Dalin; Carolyn Weinbaum; Patrick J Casey; Andrej Tarkowski; Birgitta Swolin; Stephen G Young; Martin O Bergo
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

4.  Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P.

Authors:  Philipp Markart; Nicole Faust; Thomas Graf; Cheng-Lun Na; Timothy E Weaver; Henry T Akinbi
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

5.  Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha.

Authors:  A Iwama; P Zhang; G J Darlington; S R McKercher; R Maki; D G Tenen
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

Review 6.  Alveolar epithelial type II cell: defender of the alveolus revisited.

Authors:  H Fehrenbach
Journal:  Respir Res       Date:  2001-01-15

7.  The Role of Alveolar Epithelial Type II-Like Cells in Uptake of Structurally Different Antigens and in Polarisation of Local Immune Responses.

Authors:  Johnnie Akgün; Irma Schabussova; Martin Schwarzer; Hana Kozakova; Michael Kundi; Ursula Wiedermann
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

8.  Immunohistochemical study on the secretory host defense system with lysozyme and secretory phospholipase A2 throughout rat respiratory tract.

Authors:  Natsumi Masuda; Youhei Mantani; Chiaki Yoshitomi; Hideto Yuasa; Miho Nishida; Masaya Arai; Junichi Kawano; Toshifumi Yokoyama; Nobuhiko Hoshi; Hiroshi Kitagawa
Journal:  J Vet Med Sci       Date:  2017-12-08       Impact factor: 1.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.